PI opioids op-ed in The Hill calls for holding drug manufacturers accountable for promoting “hope in a bottle”

Big Pharma sold us “hope in bottle.” It’s time to reclaim hope for our communities instead.

Civil suits will transform the way we understand the problem of opioids
The Hill, March 14, 2019
By Sarah Mittermaier and Dana Fields-Johnson of Prevention Institute

We need to get to the bottom of what drug companies have done to fuel the opioid epidemic and hold the pharmaceutical industry accountable for the damage it has unleashed.

That means fully exposing industry deception, regulatory failures, and negative public health consequences. This would ultimately harness industry profits to support treatments and also prevention.  It would also address the very conditions that left communities vulnerable to Big Pharma’s predatory marketing and sales strategies in the first place.
Pharmaceutical companies have pursued profits at enormous social costs, while leaving communities holding the bag.
That means we need to give communities the resources they need to rebuild long-underfunded public health infrastructure. We also need to address the community-level factors underlying substance misuse and other diseases of despair. This can include the need for stronger social networks, local economic development and living-wage jobs; opportunities for community members to come together to heal and thrive.

Read the full op-ed.

Click here to learn about PI’s work with 12 rural communities in Ohio developing upstream, community-level strategies to prevent opioid misuse and combat the overdose crisis.

NOTE: As we were completing this email, we began hearing about the tragic mass shooting in New Zealand. We are horrified by this act of hatred. We stand with all Muslims everywhere and will always side with love over hate.

Need Our Help?

We’ve got more than 25 years of experience supporting community collaboratives, practitioners, funders, and jurisdictions. Check out our services and reach out.